4
views
0
recommends
+1 Recommend
1 collections
    0
    shares

      Therapeutics and Clinical Risk Management (submit here)

      This international, peer-reviewed Open Access journal by Dove Medical Press focuses on reporting of clinical studies, outcomes and safety in all therapeutic areas and surgical intervention areas. Sign up for email alerts here.

      34,006 Monthly downloads/views I 2.755 Impact Factor I 4.5 CiteScore I 1.0 Source Normalized Impact per Paper (SNIP) I 0.598 Scimago Journal & Country Rank (SJR)

      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Effects of Scleral Contact Lenses for Keratoconus Management on Visual Quality and Intraocular Pressure

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Purpose

          To evaluate the visual acuity level achieved by scleral contact lens (CL) fitting in patients affected by keratoconus and to evaluate possible intraocular pressure (IOP) changes during the scleral CL wear using a transpalpebral tonometer.

          Methods

          In a prospective case series a comparison was made between visual acuity obtained with glasses, RGP and 16.8mm diameter scleral CL in 30 consecutive patients affected by keratoconus. IOP was tested during scleral CL wear by transpalpebral Diaton Tonometer (DT) and also by Goldmann Applanation Tonometer (GAT) before and after scleral CL wear.

          Results

          The mean logMAR visual acuity improved from 0.2±0.25SD with glasses and 0.1±0.02SD with RGP, to −0.002±0.041SD when using the scleral CL ( p<0.05). The mean IOP value before scleral CL wear was 12.93mmHg±2.20SD when measured with GAT and 7.85mmHg±2.27SD when measured with DT. During scleral CL wear, IOP was assessed through DT, with a mean value of 8.86mmHg±2.36SD; values were stable after 8 hours of scleral CL use. Immediately after scleral CL removal, the mean IOP measured with GAT was 12.85mmHg ±2.40SD and the mean IOP measured with DT was 7.66mmHg±1.88SD. Therefore, during scleral CL wear, it was evidenced a small but statistically significant increase of the mean IOP value (1.01mmHg; p<0.01), with a reversion to values prior to application when scleral CL was removed.

          Conclusion

          Scleral CLs remarkably improved visual acuity in keratoconus patients when compared to glasses or RGP contact lenses. Even if it was evidenced a small increase of the mean IOP value during their wear, it may not be significant in otherwise healthy eyes. Statistical analysis demonstrated good agreement between GAT and DT but their numerical values presented a constant gap, that should be taken into account when there is a need to relate the DT values to the reference ones.

          Most cited references35

          • Record: found
          • Abstract: not found
          • Article: not found

          Live-epikeratophakia for keratoconus

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found
            Is Open Access

            Scleral Lenses Reduce the Need for Corneal Transplants in Severe Keratoconus

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The genetics of keratoconus.

              Keratoconus is a bilateral, non-inflammatory corneal ectasia characterized by progressive conical thinning and protrusion of the cornea. Its etiology has long been believed to be multifactorial, with environmental, behavioral, and genetic factors all contributing to the disease process. This review focuses specifically on examining the evidence that supports a genetic basis for keratoconus.
                Bookmark

                Author and article information

                Journal
                Ther Clin Risk Manag
                Ther Clin Risk Manag
                tcrm
                tcriskman
                Therapeutics and Clinical Risk Management
                Dove
                1176-6336
                1178-203X
                25 January 2021
                2021
                : 17
                : 79-85
                Affiliations
                [1 ]Eye Clinic, Department of Sense Organs, University of Rome Sapienza, Policlinico Umberto I , Rome, Italy
                Author notes
                Correspondence: Leopoldo Spadea Eye Clinic, Policlinico Umberto 1, “Sapienza” University of Rome , Via Benozzo Gozzoli 34, Rome00142, ItalyTel +039 06 519 3220Fax +39 06 8865 7818 Email leopoldo.spadea@uniroma1.it
                Author information
                https://orcid.org/http://orcid.org/0000-0003-4941-9307
                https://orcid.org/http://orcid.org/0000-0002-1190-3956
                Article
                293425
                10.2147/TCRM.S293425
                7846850
                33531812
                131c450d-4c49-45ba-b305-2b3e854247f3
                © 2021 Formisano et al.

                This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.php).

                History
                : 26 November 2020
                : 15 January 2021
                Page count
                Figures: 3, Tables: 4, References: 35, Pages: 7
                Funding
                This research did not receive any specific grant from funding agencies in the public, commercial, or not-for profit sectors.
                Categories
                Original Research

                Medicine
                keratoconus,higher-order aberrations,iop,scleral contact lens
                Medicine
                keratoconus, higher-order aberrations, iop, scleral contact lens

                Comments

                Comment on this article